We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+5.22%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$663B
AUM Growth
+$90.2B
Cap. Flow
+$7.29B
Cap. Flow %
1.1%
Top 10 Hldgs %
28.05%
Holding
13,659
New
1,862
Increased
5,386
Reduced
4,790
Closed
1,590

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$1.41B
2
AAPL icon
Apple
AAPL
+$949M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$788M
4
MSFT icon
Microsoft
MSFT
+$654M
5
AVGO icon
Broadcom
AVGO
+$568M

Sector Composition

Rank Sector Weight
1 Miscellaneous 93.3%
2 Technology 1.97%
3 Financials 0.89%
4 Consumer Discretionary 0.83%
5 Healthcare 0.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DWSN icon
11876
Dawson Geophysical
DWSN
$100M
$25K ﹤0.01%
19,085
+6,849
+56% +$10.7K
MRDN
11877
PUT
Meridian Holdings Inc
MRDN
$180M
$24.9K ﹤0.01%
+1,050
New +$29.3K
BTLN
11878
PUT
Brightline Interactive
BTLN
$21M
$24.9K ﹤0.01%
+10,100
New +$11.2K
DADA
11879
PUT
DELISTED
Dada Nexus
DADA
$24.8K ﹤0.01%
+20,500
New +$32.8K
SPRB
11880
Spruce Biosciences
SPRB
$178M
$24.8K ﹤0.01%
+786
New +$28.8K
ICAD
11881
CALL
DELISTED
iCAD Inc
ICAD
$24.5K ﹤0.01%
+13,400
New +$23.7K
COCP icon
11882
Cocrystal Pharma
COCP
$22.2M
$24.5K ﹤0.01%
12,127
-25,673
-68% -$51.4K
CHNR icon
11883
China Natural Resources
CHNR
$4.98M
$24.3K ﹤0.01%
+4,508
New +$24.3K
FCUV icon
11884
Focus Universal
FCUV
$7.32M
$24.2K ﹤0.01%
173
-55
-24% -$5.62K
TTOO
11885
DELISTED
T2 Biosystems, Inc
TTOO
$24.2K ﹤0.01%
57,554
+12,073
+27% +$10.1K
ENZ
11886
DELISTED
Enzo Biochem, Inc.
ENZ
$24.2K ﹤0.01%
+33,835
New +$35.1K
GBIO
11887
DELISTED
Generation Bio
GBIO
$24.2K ﹤0.01%
+2,279
New +$40.6K
PRPL icon
11888
PUT
Purple Innovation
PRPL
$20.7M
$23.8K ﹤0.01%
1,220
-72
-6% -$1.63K
KZIA
11889
CALL
Kazia Therapeutics
KZIA
$190M
$23.7K ﹤0.01%
2,680
+2,392
+831% +$55.3K
BRN icon
11890
Barnwell Industries
BRN
$14M
$23.6K ﹤0.01%
15,611
-22,296
-59% -$40.7K
CVM icon
11891
PUT
CEL-SCI Corp
CVM
$27.8M
$23.4K ﹤0.01%
1,953
-1,404
-42% -$32.4K
SSP icon
11892
CALL
E.W. Scripps
SSP
$297M
$23.4K ﹤0.01%
+10,600
New +$24.5K
ANIX icon
11893
PUT
Anixa Biosciences
ANIX
$125M
$23.2K ﹤0.01%
+10,000
New +$31.1K
MAIA icon
11894
MAIA Biotechnology
MAIA
$84.6M
$23.1K ﹤0.01%
+11,649
New +$27.9K
CRBU icon
11895
CALL
Caribou Biosciences
CRBU
$178M
$22.9K ﹤0.01%
+14,400
New +$29K
GP
11896
GreenPower Motor Co
GP
$11.9M
$22.9K ﹤0.01%
+2,977
New +$29.6K
CRDL
11897
Cardiol Therapeutics
CRDL
$238M
$22.2K ﹤0.01%
17,364
-7,982
-31% -$13.5K
AP icon
11898
CALL
Ampco-Pittsburgh
AP
$187M
$21.9K ﹤0.01%
+10,500
New +$20K
SLS icon
11899
PUT
SELLAS Life Sciences
SLS
$3.06B
$21.8K ﹤0.01%
+21,000
New +$24K
NFGC
11900
PUT
New Found Gold
NFGC
$742M
$21.7K ﹤0.01%
11,900
-41,700
-78% -$85.1K

Similar funds

Jeff Yass's Q4 2024 Portfolio in Review

As of Q4 2024, Jeff Yass held 13,659 positions worth $663B, up 16% from $572B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Jeff Yass's Q4 2024 filing shows 1,862 new, 5,386 increased, 4,790 reduced and 1,590 closed positions. Its largest new stake was State Street SPDR S&P 400 Mid Cap Value ETF: 1,000,000 shares worth $80.2M. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $1.26B.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, down from 94% a quarter earlier, followed by Technology and Financials.

  • Jeff Yass's largest Q4 2024 buy was State Street SPDR S&P 400 Mid Cap Value ETF: 1,000,000 shares worth $80.2M.
  • Jeff Yass added most to Invesco QQQ Trust in Q4 2024, an estimated $1.41B increase.
  • Jeff Yass's biggest Q4 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.26B.
  • Jeff Yass fully exited NextEra Energy 7.299% Corporate Units in Q4 2024, selling an estimated $112M.
  • Jeff Yass's ten largest holdings make up 28% of its $663B portfolio in Q4 2024.
  • Jeff Yass opened 1,862 new positions and closed 1,590 in Q4 2024.
  • Jeff Yass's portfolio value rose 16% quarter-over-quarter to $663B.

Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.